Glycated hemoglobin News and Research

RSS

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

Study investigates incident diabetes burden and risk in post-acute COVID-19 patients

Researchers examined the post-acute risk and burden of incident diabetes beyond the initial 30 days of COVID-19.

25 Mar 2022

Evidence of COVID-19 impacts on glycated hemoglobin levels in a real-world clinical cohort

Researchers established the impact of SARS-CoV-2 infection on glycated hemoglobin levels, type 2 diabetes risk, and diabetic ketoacidosis through data from the large real-world clinical cohort.

17 Mar 2022

COVID-19 vaccination humoral immune response in individuals with diabetes

A new study investigated the humoral immune response and side effects related to COVID-19 vaccines in individuals with type 1 diabetes and type 2 diabetes.

12 Nov 2021

EKF Diagnostics to exhibit new STAT-Site WB β-ketone and glucose handheld analyzer at Medica 2021

EKF Diagnostics, the global in vitro diagnostics company, announces that it will be exhibiting live & in person at Medica 2021 (Hall 3 Stand B71) for the first time in mainland Europe in two years.

From EKF Diagnostics 25 Oct 2021

EKF Diagnostics to showcase at Medica 2021 STAT-Site® WB β-ketone and glucose handheld analyzer live & in person

KF Diagnostics, the global in vitro diagnostics company, announces that it will be exhibiting live & in person at Medica 2021 (Hall 3 Stand B71) for the first time in mainland Europe in two years.

21 Oct 2021

Study shows effects of COVID-19 pandemic on the health of women aged 50 to 70 years

In a study involving 34 women aged 50-70, researchers at the University of São Paulo (USP) in Brazil performed objective measurements of the impact on the subjects' health of the decrease in physical activity observed during the period of social distancing and isolation imposed by COVID-19.

30 Jun 2021

The potential therapeutic value of CDK6 inhibitors in critical COVID-19

While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of this strategy has been limited so far. A new study, released as a preprint on the medRxiv* server, describes a new method of identifying a promising hit among drugs already in use.

24 May 2021

Nemours receives grant to examine behavioral health intervention for adolescents with Type 1 diabetes

Susana R. Patton, Ph.D., ABPP, CDCES Center Director of the Nemours Center for Healthcare Delivery Science in Florida, has secured a three-year, $900,000 NIH R01 grant entitled, "Coin2Dose: Behavioral economics to promote insulin bolus activity and improve HbA1c in teens." Dr. Patton is the recipient of three concurrent R01 grants.

8 Apr 2021

Microfluidic chip and AI-powered automated microscope help measure hemoglobin levels

One of the most performed medical diagnostic tests to ascertain the health of patients is a complete blood count, which typically includes an estimate of the hemoglobin concentration.

24 Feb 2021

Study: Older adults classified as "prediabetic" seldom progress to full diabetes

Older adults who are classified as having "prediabetes" due to moderately elevated measures of blood sugar usually don't go on to develop full-blown diabetes, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

8 Feb 2021

Drug found to be safe and effective for treating patients with obesity and type 2 diabetes

A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes.

13 Jan 2021

More years of obesity means higher risk of disease, study finds

The results of a new study have revealed that the duration of obesity is correlated with worse values for all cardiometabolic disease factors.

8 Dec 2020

Continuous glucose monitoring has favorable effects over several years

New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available.

16 Nov 2020

EKF & Tosoh Europe N.V. distribution agreement expands HbA1c POC testing reach in Middle East & Africa

EKF Diagnostics, the global in vitro diagnostics company, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V. for the distribution of its Quo-Test HbA1c point-of-care analyzer in the Middle East and Africa.

From EKF Diagnostics 15 May 2020

Menopause age not associated with heart disease finds study

There has been conflicting evidence regarding early menopause and an increased risk for heart disease among women. This connection has been attributed to the lowering of female hormone estrogen levels in the blood.

26 Feb 2020

Worse long-term control of blood sugar increases risks in diabetic trauma patients

In trauma patients with diabetes, poorer long-term control of blood glucose levels is linked to a higher risk of death and trauma-related complications, reports a study in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.

18 Dec 2019